These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 33726698)
1. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma. Chen H; Li Y; Xiao SY; Guo J BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698 [TBL] [Abstract][Full Text] [Related]
2. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma. Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474 [TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data. Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866 [TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177 [TBL] [Abstract][Full Text] [Related]
6. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955 [TBL] [Abstract][Full Text] [Related]
7. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5. Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092 [TBL] [Abstract][Full Text] [Related]
8. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z Front Immunol; 2021; 12():653836. PubMed ID: 33897701 [No Abstract] [Full Text] [Related]
9. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
10. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma. Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941 [TBL] [Abstract][Full Text] [Related]
11. A new risk model comprising genes highly correlated with CD133 identifies different tumor-immune microenvironment subtypes impacting prognosis in hepatocellular carcinoma. Yu H; Zhu X; Lin H; Pan H; Zhao F; Zhu M; Sun L; Chai W; Yao M; Yan M Aging (Albany NY); 2020 Jun; 12(12):12234-12250. PubMed ID: 32564007 [TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356 [TBL] [Abstract][Full Text] [Related]
13. A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma. Liu L; Chen J; Ye F; Yan Y; Wang Y; Wu J Technol Cancer Res Treat; 2024; 23():15330338241276895. PubMed ID: 39155614 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
15. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma. Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560 [TBL] [Abstract][Full Text] [Related]
16. Immune system‑associated genes increase malignant progression and can be used to predict clinical outcome in patients with hepatocellular carcinoma. Huang R; Chen Z; Li W; Fan C; Liu J Int J Oncol; 2020 May; 56(5):1199-1211. PubMed ID: 32319580 [TBL] [Abstract][Full Text] [Related]
17. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification. Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T Front Immunol; 2024; 15():1323199. PubMed ID: 38742112 [TBL] [Abstract][Full Text] [Related]
18. Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients. Huo X; Qi J; Huang K; Bu S; Yao W; Chen Y; Nie J BMC Cancer; 2020 Aug; 20(1):771. PubMed ID: 32807131 [TBL] [Abstract][Full Text] [Related]
19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma. Zhao QJ; Zhang J; Xu L; Liu FF World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881 [TBL] [Abstract][Full Text] [Related]
20. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma. Liu T; Wu H; Qi J; Qin C; Zhu Q Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]